
| ASSET | DATE | % RETURN |
|---|---|---|
Biohaven Pharmaceutical (BHVN) | 10/1/2022 - 10/30/2022 | 139.91% |
Tango Therapeutics (TNGX) | 10/1/2022 - 10/30/2022 | 120.54% |
Enliven Therapeutics (ELVN) | 10/1/2022 - 10/30/2022 | 84.85% |
SS Innovations International Inc Common Stock (SSII) | 10/1/2022 - 10/30/2022 | 84.09% |
Avalo Therapeutics (AVTX) | 10/1/2022 - 10/30/2022 | 79.41% |
Helix Energy Solutions (HLX) | 10/1/2022 - 10/30/2022 | 59.71% |
ADEIA (ADEA) | 10/1/2022 - 10/30/2022 | 57.29% |
Nabors Industries (NBR) | 10/1/2022 - 10/30/2022 | 56.74% |
Cooper Stnd (CPS) | 10/1/2022 - 10/30/2022 | 56.67% |
Inventiva (IVA) | 10/1/2022 - 10/30/2022 | 55.73% |
Aehr Test Systems (AEHR) | 10/1/2022 - 10/30/2022 | 52.58% |
Seadrill (SDRL) | 10/1/2022 - 10/30/2022 | 48.14% |
Pacific Biosciences of California (PACB) | 10/1/2022 - 10/30/2022 | 47.8% |
Riley Exploration Permian (REPX) | 10/1/2022 - 10/30/2022 | 44.1% |
Entrada Therapeutics (TRDA) | 10/1/2022 - 10/30/2022 | 43.08% |
Byrna Technologies (BYRN) | 10/1/2022 - 10/30/2022 | 41.98% |
Oil States International (OIS) | 10/1/2022 - 10/30/2022 | 41.71% |
American Public Education (APEI) | 10/1/2022 - 10/30/2022 | 41.46% |
Citi Trends (CTRN) | 10/1/2022 - 10/30/2022 | 41.31% |
Calumet Specialty Products Partners (CLMT) | 10/1/2022 - 10/30/2022 | 41.3% |
UroGen Pharma (URGN) | 10/1/2022 - 10/30/2022 | 40.87% |
Monarch Casino & Resort (MCRI) | 10/1/2022 - 10/30/2022 | 40.41% |
Expro (XPRO) | 10/1/2022 - 10/30/2022 | 39.39% |
Value Line (VALU) | 10/1/2022 - 10/30/2022 | 38.76% |
Meihua International Medical Technologies (MHUA) | 10/1/2022 - 10/30/2022 | 38.66% |